Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
about
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneThe role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignanciesDisruptive chemicals, senescence and immortalityTherapeutic targeting of replicative immortalityAmadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cellsEnterolactone Reduces Telomerase Activity and The Level of Its Catalytic Subunit in Breast Cancer Cells.Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and TransformationIsoflavones and Prostate Cancer: A Review of Some Critical Issues.Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.The small molecule, genistein, increases hepcidin expression in human hepatocytes.Pharmaceutical regulation of telomerase and its clinical potentialGossypol suppresses telomerase activity in human leukemia cells via regulating hTERT.Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.Intronic microRNA suppresses endothelial nitric oxide synthase expression and endothelial cell proliferation via inhibition of STAT3 signaling.Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer.Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.
P2860
Q26739925-C5164626-038D-4F31-B979-14D10FEF5A45Q27008221-4F22D452-DD6E-4177-88CD-487A48B6591FQ27026235-E249F5FA-B8F9-4BC1-A262-FCA616212836Q27027457-00A3909A-F185-4765-87A1-AC34A549BF80Q28270022-EF72720A-AFC3-4B87-A61A-A75F4F1F796AQ33738088-5C357CC2-5EA4-40C2-8136-0E0AED58FDC5Q35120899-45542102-750B-4796-B7C7-A7D1BAD9B9D8Q36130808-C815CC9F-11AB-456A-9B08-84151A092B4CQ36705608-361A1912-7B82-4668-98F4-127C078E6977Q37074134-B0F8689B-D18C-463D-A580-6FA055B2D658Q37160321-9007F4A7-A0AE-4056-A296-497C312B4F33Q37164759-A8B72807-6375-4BD2-9E3E-15E6B3A8B464Q37942633-2DB1416A-C42E-4BF8-8AE3-00282478FDFBQ38499041-0215E711-ACDD-42E9-854C-2ADCAAD0E100Q38920521-9E81E5CD-EE8C-412E-AF24-800AE324FB98Q39536741-B9A1BF82-13FD-4453-BA05-E82E818AE722Q39652928-03E3AA7C-3AA9-47AD-9884-289DD454237DQ50131963-3C7F23B9-9DFE-4DB7-84BD-15D1A71BDA7AQ52331716-C6EEDAF0-7703-42E8-95CB-2A67E70573A8
P2860
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Physiologically achievable con ...... s via the activation of STAT3.
@en
type
label
Physiologically achievable con ...... s via the activation of STAT3.
@en
prefLabel
Physiologically achievable con ...... s via the activation of STAT3.
@en
P2093
P2860
P356
P1433
P1476
Physiologically achievable con ...... s via the activation of STAT3.
@en
P2093
Lara H El Touny
Partha P Banerjee
Shankar Jagadeesh
P2860
P304
P356
10.1093/CARCIN/BGM148
P407
P577
2007-07-05T00:00:00Z